NCPA’s AMP Legislative Strategy Focuses On Delay, Not Fix, For Now
Executive Summary
The National Community Pharmacists Association is working toward its goal of revamping Medicaid's average manufacturer price rules by lobbying Congress for a legislative delay in enforcing them
You may also be interested in...
Medicaid Reform: Teva Wants Payments To Encourage Generic Substitution
The overarching political priority for generic drug firms at the moment is creation of a pathway for follow-on biologics. But the industry also hopes that general healthcare reform efforts provide an opportunity to consolidate gains the sector has made around small molecule products as well
Medicaid Reform: Teva Wants Payments To Encourage Generic Substitution
The overarching political priority for generic drug firms at the moment is creation of a pathway for follow-on biologics. But the industry also hopes that general healthcare reform efforts provide an opportunity to consolidate gains the sector has made around small molecule products as well
E-Rx, Dialysis Bundling Are Likely Survivors Of Failed Medicare Doc Fix Bill
Electronic prescribing is among the handful of drug-related items likely to be revived when Finance Committee Chairman Max Baucus, D-Mont., recrafts his Medicare physician payment package to gain broader Senate support